Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved
暂无分享,去创建一个
J. Soares | C. N. Leitão | A. D. Pereira | A. Suspiro | P. Chaves | C. Ribeiro | C. Laranjeira | P. Cardoso | M. Crespo
[1] M. Danielsen,et al. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family. , 2006, Cancer genetics and cytogenetics.
[2] M. Vieth,et al. Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms , 2006, Virchows Archiv.
[3] C. N. Leitão,et al. Gastric and intestinal differentiation in Barrett's metaplasia and associated adenocarcinoma. , 2005, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[4] S. Kawauchi,et al. Two subtypes of mucinous colorectal carcinoma characterized by laser scanning cytometry and comparative genomic hybridization. , 2004, International journal of oncology.
[5] J. Soares,et al. Losses of Heterozygosity on Chromosomes 9p and 17p Are Frequent Events in Barrett’s Metaplasia Not Associated With Dysplasia or Adenocarcinoma , 2003, American Journal of Gastroenterology.
[6] G. Casey,et al. Diffuse Large B-Cell Lymphoma of the Stomach: Assessment of Microsatellite Instability, Allelic Imbalance, and Trisomy of Chromosomes 3, 12, and 18 , 2002, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[7] Patricia L. Blount,et al. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. , 2001, Cancer research.
[8] M. Copin,et al. Mucin gene expression in intestinal epithelial cells in Crohn's disease , 2001, Gut.
[9] M. Sales,et al. Chromosomal imbalances in gastric and esophageal adenocarcinoma: Specific comparative genomic hybridization–detected abnormalities segregate with junctional adenocarcinomas , 2001, Genes, chromosomes & cancer.
[10] J. Flejou,et al. Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: a study using in‐situ hybridization , 2000, Histopathology.
[11] Carissa A. Sanchez,et al. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. , 2000, Journal of the National Cancer Institute.
[12] A. Zelenetz,et al. MUC1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma. , 2000, Blood.
[13] D. Smedley,et al. Characterization of chromosome 1 abnormalities in malignant melanomas , 2000, Genes, chromosomes & cancer.
[14] S. Jhanwar,et al. MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets. , 2000, Blood.
[15] J R Siewert,et al. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. , 2000, The American journal of pathology.
[16] B. Reid,et al. p53-mutant clones and field effects in Barrett's esophagus. , 1999, Cancer research.
[17] Carissa A. Sanchez,et al. Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.
[18] M. Sobrinho-Simões,et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. , 1999, Cancer research.
[19] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[20] D. Persons,et al. Interphase cytogenetics of esophageal adenocarcinoma and precursor lesions. , 1998, Cancer genetics and cytogenetics.
[21] Kenneth K Wang,et al. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.
[22] R. Sampliner,et al. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.
[23] A. Cameron,et al. Epidemiology of columnar-lined esophagus and adenocarcinoma. , 1997, Gastroenterology clinics of North America.
[24] D. Levine. Management of dysplasia in the columnar-lined esophagus. , 1997, Gastroenterology clinics of North America.
[25] D. Crawford,et al. A technique for the culture of Barrett's oesophageal cells , 1997, Journal of gastroenterology and hepatology.
[26] F. Borchard,et al. A new aspect of gastric metaplasia in Crohn's disease: Bidirectional (foveolar and pyloric) differentiation in so‐called ‘pyloric metaplasia’ in the ileum , 1997, Pathology international.
[27] P. Roepstorff,et al. Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody , 1997, International journal of cancer.
[28] F. Offner,et al. Metaplastic columnar cells in Barrett's esophagus: a common and neglected cell type. , 1996, Human pathology.
[29] A. Hagemeijer,et al. Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. , 1996, Cancer genetics and cytogenetics.
[30] Carissa A. Sanchez,et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Ippoliti,et al. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. , 1996, Gastrointestinal endoscopy.
[32] R. Goyal,et al. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. , 1996, Gastroenterology.
[33] F. Mitelman. ISCN 1995 : an international system for human cytogenetic nomenclature (1995) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature : Memphis, Tennessee, USA, October 9-13, 1994 , 1995 .
[34] E. Furth,et al. Barrett's Esophagus, Dysplasia, and Adenocarcinoma , 1995 .
[35] Y. Kim,et al. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. , 1995, Cancer research.
[36] W. Hop,et al. Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus. , 1995, Cancer research.
[37] R. Haggitt,et al. Barrett's esophagus, dysplasia, and adenocarcinoma. , 1994, Human pathology.
[38] H. van Dekken,et al. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry. , 1994, Cytometry.
[39] S. Hunter,et al. Y chromosome loss in esophageal carcinoma: An in situ hybridization study , 1993, Genes, chromosomes & cancer.
[40] D. Beer,et al. Amplification and over‐expression of the EGFR and erbB‐2 genes in human esophageal adenocarcinomas , 1993, International journal of cancer.
[41] D. Hopwood,et al. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. , 1993, The American journal of gastroenterology.
[42] F. Mitelman,et al. Improved technique for short‐term culture and cytogenetic analysis of human breast cancer , 1992, Genes, chromosomes & cancer.
[43] B. Reid,et al. Persistent clonal areas and clonal expansion in Barrett's esophagus. , 1992, Cancer research.
[44] M. Hendrix,et al. Tissue culture of epithelial cells from esophageal specialized columnar epithelium (Barrett's esophagus) , 1992, Digestive Diseases and Sciences.
[45] D. Ledbetter,et al. Localization of the cellular retinoic acid binding protein (CRABP) gene relative to the acute promyelocytic leukemia-associated breakpoint on human chromosome 15 , 1991, Human Genetics.
[46] J. Fraumeni,et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.
[47] J. Trent,et al. Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma. , 1989, Cancer genetics and cytogenetics.
[48] R C Heading,et al. Barrett's oesophagus. , 1987, British medical journal.
[49] R. Goyal,et al. The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.
[50] T. Hanaoka,et al. Recent Advances in Diseases of the Esophagus , 1993, Springer Japan.
[51] Iscn. International System for Human Cytogenetic Nomenclature , 1978 .